Parmax Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 7.82 | 4.27 | 1.34 |
| Operating Expense | 7.30 | 5.06 | 2.48 |
| Net Profit | 0.01 | -1.45 | -1.75 |
| Net Profit Margin | 0.13 | -33.96 | -130.60 |
| Earning Per Share | 0.03 | -3.88 | -4.68 |
| EBIDTA | 0.52 | -0.75 | -1.14 |
| Effective Tax Rate | TBA | -16.46 | TBA |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 7.82 |
| Operating Expense | 7.30 |
| Net Profit | 0.01 |
| Net Profit Margin | 0.13 |
| Earning Per Share | 0.03 |
| EBIDTA | 0.52 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Total Revenue Annual | 15.42 | 18.25 | 26.20 |
| Operating Expenses Annual | 13.17 | 15.69 | 22.79 |
| Operating Profit Annual | 2.29 | 2.62 | 3.50 |
| Interest Annual | 0.37 | 0.39 | 0.35 |
| Depreciation | 1.88 | 1.93 | 1.94 |
| Net Profit Annual | -0.10 | 0.14 | 0.75 |
| Tax Annual | 0.15 | 0.16 | 0.45 |
| Particulars | Mar 2023 |
|---|---|
| Total Revenue Annual | 15.42 |
| Operating Expenses Annual | 13.17 |
| Operating Profit Annual | 2.29 |
| Interest Annual | 0.37 |
| Depreciation | 1.88 |
| Net Profit Annual | -0.10 |
| Tax Annual | 0.15 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Cash Flow at the Beginning | 1.05 | 2.75 | 1.97 |
| Cash Flow from Operations | 0.33 | 0.75 | 3.53 |
| Cash Flow from Investing | -0.94 | -1.53 | -3.15 |
| Cash Flow from Financing | -0.04 | -0.91 | 0.40 |
| Cash Flow at the End | 0.41 | 1.05 | 2.75 |
| Particulars | Mar 2023 |
|---|---|
| Cash Flow at the Beginning | 1.05 |
| Cash Flow from Operations | 0.33 |
| Cash Flow from Investing | -0.94 |
| Cash Flow from Financing | -0.04 |
| Cash Flow at the End | 0.41 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| PBDIT Margin (%) | 15.05 | 14.41 | 13.44 |
| PBIT Margin (%) | 2.85 | 3.84 | 6.03 |
| PBT Margin (%) | -4.48 | -5.86 | -10.15 |
| Net PROFIT Margin (%) | -0.65 | 0.77 | 2.86 |
| Return On Networth / Equity (%) | -1.69 | 2.38 | 13.79 |
| Return On Networth /Employed (%) | 4.03 | 6.04 | 14.26 |
| Return On Assets (%) | -0.89 | 1.23 | 6.81 |
| Total Debt / Equity (X) | 0.89 | 0.94 | 1.02 |
| Asset Turnover Ratio (%) | 1.38 | 1.60 | 2.38 |
| Particulars | Mar 2023 |
|---|---|
| PBDIT Margin (%) | 15.05 |
| PBIT Margin (%) | 2.85 |
| PBT Margin (%) | -4.48 |
| Net PROFIT Margin (%) | -0.65 |
| Return On Networth / Equity (%) | -1.69 |
| Return On Networth /Employed (%) | 4.03 |
| Return On Assets (%) | -0.89 |
| Total Debt / Equity (X) | 0.89 |
| Asset Turnover Ratio (%) | 1.38 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Fixed Assets Annual | 9.50 | 10.44 | 10.84 |
| Total Current Assets Annual | 7.53 | 6.56 | 10.34 |
| Non Current Assets Annual | 10.08 | 11.42 | 12.39 |
| Total Shareholders Funds Annual | 5.86 | 5.96 | 5.82 |
| Total Assets Annual | 17.61 | 17.97 | 22.73 |
| Particulars | Mar 2023 |
|---|---|
| Fixed Assets Annual | 9.50 |
| Total Current Assets Annual | 7.53 |
| Non Current Assets Annual | 10.08 |
| Total Shareholders Funds Annual | 5.86 |
| Total Assets Annual | 17.61 |
No Data Availabe
